Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (401-410 of 568) with videos related to

Pageof 57
Sort By:
International Journal of Molecular Sciences|November 14, 2023
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their ModulationMontse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, et al.
The American Journal of Gastroenterology|January 13, 2016
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC StudyIgnacio Marín-Jiménez, Pilar Nos, Eugeni Domènech, et al.
International Journal of Molecular Sciences|May 27, 2023
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF DrugsRosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez, et al.
Inflammatory Bowel Diseases|July 4, 2017
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative ColitisCarlos Taxonera, Cristina Rodríguez, Federico Bertoletti, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2014
Accuracy of GastroPanel for the diagnosis of atrophic gastritisAdrian G McNicholl, Montserrat Forné, Jesus Barrio, et al.
Digestive Diseases and Sciences|June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative ColitisCarlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in SpainMaría Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, et al.
European Journal of Immunology|February 24, 2026
Type 1 and CD103<sup>+</sup> Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's DiseaseElisa Arribas-Rodríguez, Carolina G de Castro, Aida Fiz-López, et al.
Journal of Clinical Medicine|November 4, 2020
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort StudyMariangela Allocca, María Chaparro, Haidee Aleman Gonzalez, et al.
Digestive Diseases and Sciences|November 15, 2018
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease PatientsMaría Chaparro, Manuel Barreiro-de Acosta, Ana Echarri, et al.
Pageof 57

Showing results (401-410 of 568) with videos related to

Sort By:
Pageof 57
International Journal of Molecular Sciences|November 14, 2023
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their ModulationMontse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, et al.
The American Journal of Gastroenterology|January 13, 2016
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC StudyIgnacio Marín-Jiménez, Pilar Nos, Eugeni Domènech, et al.
International Journal of Molecular Sciences|May 27, 2023
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF DrugsRosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez, et al.
Inflammatory Bowel Diseases|July 4, 2017
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative ColitisCarlos Taxonera, Cristina Rodríguez, Federico Bertoletti, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2014
Accuracy of GastroPanel for the diagnosis of atrophic gastritisAdrian G McNicholl, Montserrat Forné, Jesus Barrio, et al.
Digestive Diseases and Sciences|June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative ColitisCarlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in SpainMaría Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, et al.
European Journal of Immunology|February 24, 2026
Type 1 and CD103<sup>+</sup> Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's DiseaseElisa Arribas-Rodríguez, Carolina G de Castro, Aida Fiz-López, et al.
Journal of Clinical Medicine|November 4, 2020
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort StudyMariangela Allocca, María Chaparro, Haidee Aleman Gonzalez, et al.
Digestive Diseases and Sciences|November 15, 2018
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease PatientsMaría Chaparro, Manuel Barreiro-de Acosta, Ana Echarri, et al.
Pageof 57